N
Nathalie Charland
Researcher at Université de Montréal
Publications - 30
Citations - 755
Nathalie Charland is an academic researcher from Université de Montréal. The author has contributed to research in topics: Medicine & Streptococcus suis. The author has an hindex of 8, co-authored 21 publications receiving 600 citations.
Papers
More filters
Journal ArticleDOI
Streptococcus suis serotype 2 mutants deficient in capsular expression.
TL;DR: Isogenic mutants defective in capsule production demonstrate the importance of capsular polysaccharides as a virulence factor for S. suis type 2.
Journal ArticleDOI
Streptococcus suis serotype 2 interactions with human brain microvascular endothelial cells
Nathalie Charland,Victor Nizet,Craig E. Rubens,Kwang Sik Kim,Sonia Lacouture,Marcelo Gottschalk +5 more
TL;DR: Invasion assays performed with BMEC and human umbilical vein endothelial cells demonstrated that unlike GBS, S. suisserotype 2 could not invade either type of cell, and it is possible that hemolysin-positive S.suis strains use adherence and suilysin-induced BMEC injury, as opposed to direct cellular invasion, to proceed from the circulation to the central nervous system.
Journal ArticleDOI
Prevention of Pneumococcal Disease in Mice Immunized with Conserved Surface-Accessible Proteins
Josee Hamel,Nathalie Charland,Pineau Isabelle,Ouellet Catherine,Stephane Rioux,Denis Martin,Bernard R. Brodeur +6 more
TL;DR: It is demonstrated that immunization of mice with BVH-3 elicits protective immunity against experimental sepsis and pneumonia, and BVh-3 and the chimeric protein hold strong promise as vaccine components to control pneumococcal disease.
Journal ArticleDOI
Transcriptional regulation, occurrence and putative role of the Pht family of Streptococcus pneumoniae.
Stephane Rioux,Cecile Anne Neyt,Emmanuel Di Paolo,Laurence Turpin,Nathalie Charland,Steve Labbé,Marie-Cécile Mortier,Timothy J. Mitchell,Christiane Feron,Denis Martin,Jan Poolman +10 more
TL;DR: It is suggested that the Pht proteins are zinc and manganese scavengers, and are able to store these metals and to release them when the bacterium faces an ion-restricted environment.
Journal ArticleDOI
Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine
Karen Hager,Gonzalo Pérez Marc,Philipe Gobeil,Ricardo Sobhie Diaz,Gretchen M. Heizer,Conrado J. Llapur,Alexander I. Makarkov,Eduardo Vasconcellos,Stéphane Pillet,F Riera,Pooja Saxena,Priscila Geller Wolff,Kapil Bhutada,Garry Wallace,H.A. Aazami,Christine E. Jones,Fernando P. Polack,Luciana Ferrara,Judith Atkins,Iohann Boulay,Jiwanjeet Dhaliwall,Nathalie Charland,Manon Couture,J. Jiang-Wright,Nathalie Landry,Sophie Lapointe,Aurélien Lorin,Asif Mahmood,Lawrence H. Moulton,Emily Pahmer,Julie Parent,Annie Séguin,Luan Tran,Thomas Breuer,Maria Angeles Ceregido,Marguerite Koutsoukos,François Roman,Junya Namba,Marc-André D'Aoust,Sonia Trépanier,Yosuke Kimura,Brian J. Ward +41 more
TL;DR: The CoVLP+AS03 vaccine was effective in preventing Covid-19 caused by a spectrum of variants, with efficacy ranging from 69.5% against symptomatic infection to 78.8% against moderate-to-severe disease.